Sato S - Search Results

1

Clinical significance of serum growth differentiation factor-15 levels in systemic sclerosis: association with disease severity.

Yanaba K, Asano Y, Tada Y, Sugaya M, Kadono T, Sato S. Yanaba K, et al. Among authors: sato s. Mod Rheumatol. 2012 Sep;22(5):668-75. doi: 10.1007/s10165-011-0568-7. Epub 2011 Dec 9. Mod Rheumatol. 2012. PMID: 22160844

2

CD19-dependent B lymphocyte signaling thresholds influence skin fibrosis and autoimmunity in the tight-skin mouse.

Saito E, Fujimoto M, Hasegawa M, Komura K, Hamaguchi Y, Kaburagi Y, Nagaoka T, Takehara K, Tedder TF, Sato S. Saito E, et al. Among authors: sato s. J Clin Invest. 2002 Jun;109(11):1453-62. doi: 10.1172/JCI15078. J Clin Invest. 2002. PMID: 12045259 Free PMC article.

3

Function blocking autoantibodies against matrix metalloproteinase-1 in patients with systemic sclerosis.

Sato S, Hayakawa I, Hasegawa M, Fujimoto M, Takehara K. Sato S, et al. J Invest Dermatol. 2003 Apr;120(4):542-7. doi: 10.1046/j.1523-1747.2003.12097.x. J Invest Dermatol. 2003. PMID: 12648215

4

Evaluation of functional disability using the health assessment questionnaire in Japanese patients with systemic sclerosis.

Kuwana M, Sato S, Kikuchi K, Kawaguchi Y, Fujisaku A, Misaki Y, Hatamochi A, Kondo H, Takehara K. Kuwana M, et al. Among authors: sato s. J Rheumatol. 2003 Jun;30(6):1253-8. J Rheumatol. 2003. PMID: 12784399

5

Serum concentrations of the CXC chemokines interleukin 8 and growth-regulated oncogene-alpha are elevated in patients with systemic sclerosis.

Furuse S, Fujii H, Kaburagi Y, Fujimoto M, Hasegawa M, Takehara K, Sato S. Furuse S, et al. Among authors: sato s. J Rheumatol. 2003 Jul;30(7):1524-8. J Rheumatol. 2003. PMID: 12858452

6

Serum levels of tumor necrosis factor and interleukin-13 are elevated in patients with localized scleroderma.

Hasegawa M, Sato S, Nagaoka T, Fujimoto M, Takehara K. Hasegawa M, et al. Among authors: sato s. Dermatology. 2003;207(2):141-7. doi: 10.1159/000071783. Dermatology. 2003. PMID: 12920362

7

Anti-DNA topoisomerase IIalpha autoantibodies in localized scleroderma.

Hayakawa I, Hasegawa M, Takehara K, Sato S. Hayakawa I, et al. Among authors: sato s. Arthritis Rheum. 2004 Jan;50(1):227-32. doi: 10.1002/art.11432. Arthritis Rheum. 2004. PMID: 14730620

8

Elevated circulating CD40L concentrations in patients with systemic sclerosis.

Komura K, Sato S, Hasegawa M, Fujimoto M, Takehara K. Komura K, et al. Among authors: sato s. J Rheumatol. 2004 Mar;31(3):514-9. J Rheumatol. 2004. PMID: 14994397

9

Novel autoantibody to Cu/Zn superoxide dismutase in patients with localized scleroderma.

Nagai M, Hasegawa M, Takehara K, Sato S. Nagai M, et al. Among authors: sato s. J Invest Dermatol. 2004 Mar;122(3):594-601. doi: 10.1111/j.0022-202X.2004.22333.x. J Invest Dermatol. 2004. PMID: 15086540

10

The diagnostic value of oesophageal transit scintigraphy for evaluating the severity of oesophageal complications in systemic sclerosis.

Nakajima K, Kawano M, Kinuya K, Sato S, Takehara K, Tonami N. Nakajima K, et al. Among authors: sato s. Nucl Med Commun. 2004 Apr;25(4):375-81. doi: 10.1097/00006231-200404000-00010. Nucl Med Commun. 2004. PMID: 15097812

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results